Sign inJoin waitlistJoin the waitlist

DI

David Ilson

Attending Physician · New York Presbyterian Hospital

Credentials: · · · · · ·

History

Memorial Sloan Kettering Monmouth
2019–Present

Memorial Sloan Kettering Cancer Center
1989–1991
Internal Medicine
NYU Langone Hospitals
1986–1989
New York University
New York University Grossman School of Medicine
1982–1986

Research

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2022 · 1,452 citations
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2019 · 825 citations
Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2016 · 750 citations

DK
David Kelsen
70 papers
GK
Geoffrey Ku
58 papers · 6 as a fellow
YJ
Yelena Janjigian
43 papers
VS
Vivian Strong
34 papers
Jaffer Ajani
29 papers
LT
Laura Tang
29 papers
Manjit Bains
27 papers
EO
Eileen O'Reilly
22 papers · 4 as a fellow
Bruce Minsky
19 papers
DC
Daniel Coit
19 papers
LS
Leonard Saltz
19 papers
SM
Steven Maron
19 papers

Clinical trials

Sorafenib for Patients With Metastatic or Recurrent Esophageal and Gastroesophageal Junction Cancer
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2009–2018
Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2008–2015
Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2006–2012
Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2006–2010